Hyundai Bioscience Co., Ltd.
Hyundai Bioscience Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2) | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 2 / Phase 3 | 2026-07-10 | NCT07576868 | |
| Safety, Tolerability, and Efficacy of CP-PCA07 in Combination With Enzalutamide in Patients With Castration-Resistant Prostate Cancer | Castration-Resistant Prostate Cancer (CRPC) | Not yet recruiting | Phase 1 | 2026-07-06 | NCT07683013 |